WHO releases global report, consolidated guidelines to tackle viral hepatitis
“The WHO “Global hepatitis report 2024: action for access in low- and middle-income countries” is the first consolidated WHO report on viral hepatitis epidemiology, service coverage and product access, with improved data for action.“
Study Finds One-Third of Eligible Patients Decline “Opt-Out” HIV, HCV Testing
“The study involved a retrospective, medical record review of adults seen at an internal medicine outpatient resident continuity clinic in South Carolina and found approximately one-third of eligible individuals declined HIV/HCV testing. Although non-Hispanic Black individuals were the least likely to decline testing among all race/ethnicity groups, notable sex disparities were observed among Black patients.”
Hepatitis C: A once incurable infection can now be cured with 8 weeks of medication
“Hepatitis C is a liver disease caused by the hepatitis C (“hep C”) virus. Left untreated, hep C can severely damage the liver, causing illnesses like cirrhosis and liver cancer. The good news is that hep C can be completely cured. We sat down with Amber Casey, HCV (Hepatitis C Virus) Program Manager with Public Health, to learn more.”
Martin Phillips remembered as a champion for hepatitis C sufferers
“Since his death last week tributes have flowed for Martin Phillipps, the late frontman of seminal New Zealand band The Chills. While his influence on New Zealand and the wider international music scene has been at the forefront of those tributes, his openness about living with hepatitis C has also been championed.”
The Interplay of Chronic Hepatitis C and COVID-19: Implications for Prognosis and Treatment
“Conclusion: Patients with CHC and SARS-CoV-2 infection have a substantial risk of severe outcomes. Early identification and management of these patients are crucial to improve their prognosis.”
Current HCV Screening, Treatment Strategies Projected to Fall Short of WHO Goals
“Projections from an agent-based model based on data from Ontario, Canada, suggest both current and prospective strategies may not meet World Health Organization HCV goals.”
